Listeria monocytogenes bacteriophages and uses thereof
AssigneeIntralytix, Inc.
InventorsGary Pasternack, Alexander Sulakelidze
Life of this patent
Estimating the term…
Abstract
The present invention is directed to isolated bacteriophages having specificity and lytic activity against strains of Listeria species, methods of using the bacteriophages, progeny and derivatives derived therefrom, to control the growth of Listeria species in various settings (e.g., food safety, sanitation, probiotics).
Claims10
An isolated bacteriophage LMSP-25 deposited under ATCC Accession No. PTA-8353, LMTA-34 deposited under ATCC Accession No. PTA-8354, LMTA-57 deposited under ATCC Accession No. PTA-8355, LMTA-94 deposited under ATCC Accession No. PTA-8356, or LMTA-148 deposited under ATCC Accession No. 8357, said bacteriophage having lytic activity against Listeria strains, and variants thereof, wherein said variants retain the phenotypic characteristics of said bacteriophage and wherein said bacteriophage and variants thereof have lytic activity against Listeria strains.
A method for the reduction in the incidence of food borne illnesses caused by Listeria strains comprising contacting a food product or products with a microbial growth inhibiting effective amount of a bacteriophage composition comprising at least one of the isolated bacteriophage LMSP-25 deposited under ATCC Accession No. PTA-8353, LMTA-34 deposited under ATCC Accession No. PTA-8354, LMTA-57 deposited under ATCC Accession No. PTA-8355, LMTA-94 deposited under ATCC Accession No. PTA-8356, or LMTA-148 deposited under ATCC Accession No. 8357, said bacteriophage having lytic activity against Listeria strains, and variants thereof, wherein said variants retain the phenotypic characteristics of said bacteriophage and wherein said bacteriophage and variants thereof have lytic activity against Listeria strains.
Dependencies are inferred from the claim text.